Page last updated: 2024-09-03

nifekalant hydrochloride and Aging

nifekalant hydrochloride has been researched along with Aging in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hayashi, M; Kato, T; Kobayashi, Y; Morita, N; Sato, N; Takano, T; Tanaka, K; Yasutake, M1

Trials

1 trial(s) available for nifekalant hydrochloride and Aging

ArticleYear
Enhancing electrical cardioversion and preventing immediate reinitiation of hemodynamically deleterious atrial fibrillation with class III drug pretreatment.
    Journal of cardiovascular electrophysiology, 2005, Volume: 16, Issue:7

    Topics: Aged; Aging; Anti-Arrhythmia Agents; Atrial Fibrillation; Electric Countershock; Female; Hemodynamics; Hospital Mortality; Humans; Male; Middle Aged; Premedication; Prognosis; Pyrimidinones; Secondary Prevention; Treatment Failure; Treatment Outcome

2005